Artemio Mojón

7.8k total citations · 2 hit papers
150 papers, 5.7k citations indexed

About

Artemio Mojón is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Artemio Mojón has authored 150 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Cardiology and Cardiovascular Medicine, 29 papers in Surgery and 20 papers in Nutrition and Dietetics. Recurrent topics in Artemio Mojón's work include Blood Pressure and Hypertension Studies (124 papers), Heart Rate Variability and Autonomic Control (77 papers) and Cardiovascular Health and Disease Prevention (28 papers). Artemio Mojón is often cited by papers focused on Blood Pressure and Hypertension Studies (124 papers), Heart Rate Variability and Autonomic Control (77 papers) and Cardiovascular Health and Disease Prevention (28 papers). Artemio Mojón collaborates with scholars based in Spain, United States and Italy. Artemio Mojón's co-authors include José R. Fernández, Ramón C. Hermida, Diana E. Ayala, Carlos Calvo, Michael H. Smolensky, M. J. Fontao, José Enrique López, Ignacio Alonso, Marta Iglesias and Ramón C. Hermida and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Artemio Mojón

144 papers receiving 5.6k citations

Hit Papers

INFLUENCE OF CIRCADIAN TIME OF HYPERTENSION TREATMENT ON ... 2010 2026 2015 2020 2010 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. INFLUENCE OF CIRCADIAN TIME OF HYPERTENSION TREATMENT ON CARDIOVASCULAR RISK: RESULTS OF THE MAPEC STUDY
    2010 414 citations Ramón C. Hermida, Diana E. Ayala et al. Chronobiology International profile →
  2. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
    2019 257 citations Ramón C. Hermida, Juan J. Crespo et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Artemio Mojón Spain 45 4.1k 1.4k 901 880 611 150 5.7k
José R. Fernández Spain 50 4.5k 1.1× 1.6k 1.1× 1.1k 1.2× 1.0k 1.2× 872 1.4× 236 7.8k
Diana E. Ayala Spain 52 5.4k 1.3× 1.9k 1.3× 1.2k 1.3× 1.2k 1.3× 794 1.3× 218 7.9k
Ramón C. Hermida Spain 57 6.5k 1.6× 2.8k 2.0× 1.5k 1.7× 1.5k 1.7× 1.3k 2.2× 267 10.3k
Martin G. Myers Canada 40 5.8k 1.4× 557 0.4× 826 0.9× 2.6k 3.0× 856 1.4× 131 9.3k
Giuseppe Mancia Italy 56 9.5k 2.3× 1.1k 0.8× 846 0.9× 2.7k 3.0× 1.3k 2.2× 210 11.7k
Satoshi Hoshide Japan 50 8.1k 2.0× 702 0.5× 1.3k 1.4× 1.9k 2.2× 1.0k 1.6× 373 10.7k
Michael Bursztyn Israel 31 1.6k 0.4× 226 0.2× 455 0.5× 522 0.6× 647 1.1× 155 3.5k
Grzegorz Bilo Italy 40 3.5k 0.8× 733 0.5× 362 0.4× 898 1.0× 627 1.0× 160 5.2k
Carlo Porcellati Italy 41 7.9k 1.9× 381 0.3× 751 0.8× 1.6k 1.8× 587 1.0× 90 9.5k
Rosa María Bruno Italy 36 2.7k 0.7× 216 0.2× 311 0.3× 585 0.7× 783 1.3× 184 5.3k

Countries citing papers authored by Artemio Mojón

Since Specialization
Citations

This map shows the geographic impact of Artemio Mojón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artemio Mojón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artemio Mojón more than expected).

Fields of papers citing papers by Artemio Mojón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Artemio Mojón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artemio Mojón. The network helps show where Artemio Mojón may publish in the future.

Co-authorship network of co-authors of Artemio Mojón

This figure shows the co-authorship network connecting the top 25 collaborators of Artemio Mojón. A scholar is included among the top collaborators of Artemio Mojón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artemio Mojón. Artemio Mojón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermida, Ramón C., Michael H. Smolensky, Artemio Mojón, & José R. Fernández. (2023). Critical appraisal of recent translational chronopharmacology and chronotherapeutic reviews, meta-analyses, and pragmatic patient trials discloses significant deficiencies of design and conduct and suspect findings. Chronobiology International. 40(8). 1146–1167. 5 indexed citations
2.
3.
Hermida, Ramón C., et al.. (2021). Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials. Advanced Drug Delivery Reviews. 170. 200–213. 21 indexed citations
4.
Hermida, Ramón C., Michael H. Smolensky, Artemio Mojón, et al.. (2020). Does Timing of Antihypertensive Medication Dosing Matter?. Current Cardiology Reports. 22(10). 118–118. 13 indexed citations
5.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, et al.. (2020). Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure. Revista Española de Cardiología (English Edition). 74(11). 953–961. 5 indexed citations
6.
Hermida, Ramón C., Juan J. Crespo, Manuel Domínguez-Sardiña, et al.. (2019). Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. European Heart Journal. 41(48). 4565–4576. 257 indexed citations breakdown →
7.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, et al.. (2014). Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction. Journal of Human Hypertension. 28(10). 567–574. 27 indexed citations
8.
Hermida, Ramón C., Diana E. Ayala, Michael H. Smolensky, et al.. (2013). Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nature Reviews Nephrology. 9(6). 358–368. 43 indexed citations
9.
Ayala, Diana E., Ramón C. Hermida, Artemio Mojón, & José R. Fernández. (2012). Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure–Lowering Medications. Chronobiology International. 30(1-2). 340–352. 68 indexed citations
10.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, & José R. Fernández. (2012). Cardiovascular Risk of Essential Hypertension: Influence of Class, Number, and Treatment-Time Regimen of Hypertension Medications. Chronobiology International. 30(1-2). 315–327. 56 indexed citations
11.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, & José R. Fernández. (2012). Role of Time-of-Day of Hypertension Treatment on the J-Shaped Relationship Between Blood Pressure and Cardiovascular Risk. Chronobiology International. 30(1-2). 328–339. 28 indexed citations
12.
Hermida, Ramón C., Diana E. Ayala, Juan J. Crespo, et al.. (2012). Influence of Age and Hypertension Treatment-time on Ambulatory Blood Pressure in Hypertensive Patients. Chronobiology International. 30(1-2). 176–191. 34 indexed citations
13.
Mojón, Artemio, Diana E. Ayala, Alfonso Otero, et al.. (2012). Comparison of Ambulatory Blood Pressure Parameters of Hypertensive Patients With and Without Chronic Kidney Disease. Chronobiology International. 30(1-2). 145–158. 103 indexed citations
14.
Ayala, Diana E., Ana Moyá, Juan J. Crespo, et al.. (2012). Circadian Pattern of Ambulatory Blood Pressure in Hypertensive Patients With and Without Type 2 Diabetes. Chronobiology International. 30(1-2). 99–115. 90 indexed citations
15.
Hermida, Ramón C., Diana E. Ayala, José R. Fernández, et al.. (2012). Administration-Time Differences in Effects of Hypertension Medications on Ambulatory Blood Pressure Regulation. Chronobiology International. 30(1-2). 280–314. 91 indexed citations
16.
Crespo, Juan J., Alfonso Otero, María T. Ríos, et al.. (2012). Administration-Time-Dependent Effects of Hypertension Treatment on Ambulatory Blood Pressure in Patients With Chronic Kidney Disease. Chronobiology International. 30(1-2). 159–175. 45 indexed citations
17.
Moyá, Ana, Juan J. Crespo, Diana E. Ayala, et al.. (2012). Effects of Time-of-Day of Hypertension Treatment on Ambulatory Blood Pressure and Clinical Characteristics of Patients With Type 2 Diabetes. Chronobiology International. 30(1-2). 116–131. 29 indexed citations
18.
Hermida, Ramón C., Diana E. Ayala, Artemio Mojón, & José R. Fernández. (2011). Sleep-Time Blood Pressure as a Therapeutic Target for Cardiovascular Risk Reduction in Type 2 Diabetes. American Journal of Hypertension. 25(3). 325–334. 59 indexed citations
19.
Hermida, Ramón C., Diana E. Ayala, M. J. Fontao, Artemio Mojón, & José R. Fernández. (2010). CHRONOTHERAPY WITH VALSARTAN/AMLODIPINE FIXED COMBINATION: IMPROVED BLOOD PRESSURE CONTROL OF ESSENTIAL HYPERTENSION WITH BEDTIME DOSING. Chronobiology International. 27(6). 1287–1303. 56 indexed citations
20.
Hermida, Ramón C., Carlos Calvo, Diana E. Ayala, et al.. (2005). Administration Time‐Dependent Effects of Valsartan on Ambulatory Blood Pressure in Elderly Hypertensive Subjects. Chronobiology International. 22(4). 755–776. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José R. Fernández Breakdown of academic impact, for papers by Diana E. Ayala Breakdown of academic impact, for papers by Ramón C. Hermida Breakdown of academic impact, for papers by Martin G. Myers Breakdown of academic impact, for papers by Giuseppe Mancia Breakdown of academic impact, for papers by Satoshi Hoshide Breakdown of academic impact, for papers by Michael Bursztyn Breakdown of academic impact, for papers by Grzegorz Bilo Breakdown of academic impact, for papers by Carlo Porcellati Breakdown of academic impact, for papers by Rosa María Bruno
Rankless by CCL
2026